Nicola Travierso, Founder and President Velit Biopharma s.r.l
Nicola founded NTC in 2002. From inception, he led it into the operation of a solid level of excellence in marketing generic products, with sales agreements in more than 30 countries worldwide. He was successful in 2005 when he exited his first venture when NTC was acquired by a private equity fund.
He is the founder of Velit. Velit is a new high technology venture and they develop and market biosimilars, oncologicals, nanotechnological products and orphan drug molecules to pharma companies and distributors around the world under private label.
Leave A Comment